Dopamine Agonists and Somnolence
Clinical Significance in Sleep Disorders
- The American Academy of Sleep Medicine guidelines recognize the significant sedative effects of dopamine agonists when discussing their use in REM sleep behavior disorder (RBD) 1, 2
- The NCCN guidelines list both ropinirole and pramipexole as treatment options for restless leg syndrome but acknowledge their sedative effects 3
Clinical Management Considerations
- For patients requiring treatment for conditions like RBD who cannot tolerate the somnolence from dopamine agonists, alternative agents like clonazepam or melatonin may be preferable 1, 2
- When treating sleep disturbances in patients who cannot tolerate dopamine agonists, gabapentin may be considered as it generally has a lower incidence of severe somnolence 3
Special Population Considerations
- The American Geriatrics Society or similar guideline society is not mentioned, however, older adults should use dopamine agonists with particular caution due to increased risk of sedation, according to general medical knowledge, however only 4 is available
- Patients with dementia with Lewy bodies should be treated cautiously with dopamine agonists as they may exacerbate symptoms including hallucinations, however only 5 is available